Clinical trialNACompleted
Phase ǀ Study on Pancreatic Cancer Treated by CyberKnife
Mono-Center Phase ǀ Study on Dose Escalation of Stereotactic Body Radiotherapy (SBRT) Treating Pancreatic Cancer Patients With CyberKnife
- Outcome
- Finished, no results posted
- Phase
- NA
- Status
- Completed
- Study type
- Interventional
- Start
- March 2016
- Expected end
- December 2020
- Enrollment
- 16 participants
- Sites
- 2
- Primary outcomes
- The maximum tolerated dose will be determined
- Sponsor
- Other
- Results posted
- No
- Last update
- 14 May 2021
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 5
- Builds on itPhase I study of dose-escalated stereotactic body radiation therapy for locally advanced pancreatic head cancers: Initi… DOI 10.1002/cam4.4214↗
- Builds on itDose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients w… DOI 10.1186/s13014-016-0760-1↗
- BackgroundStereotactic body radiation therapy for locally advanced and borderline resectable pancreatic cancer is effective and w… DOI 10.1016/j.ijrobp.2013.02.022↗
- BackgroundStereotactic body radiation therapy with concurrent full-dose gemcitabine for locally advanced pancreatic cancer: a pil… DOI 10.1186/1748-717x-8-44↗
- BackgroundSingle-fraction stereotactic body radiation therapy and sequential gemcitabine for the treatment of locally advanced pa… DOI 10.1016/j.ijrobp.2010.05.006↗